Impact of Antecedent Infections on the Antibodies against Gangliosides and Ganglioside Complexes in Guillain-Barré Syndrome: A Correlative Study
- PMID: 35936588
- PMCID: PMC9350806
- DOI: 10.4103/aian.aian_121_22
Impact of Antecedent Infections on the Antibodies against Gangliosides and Ganglioside Complexes in Guillain-Barré Syndrome: A Correlative Study
Abstract
Background and aims: Guillain-Barré Syndrome (GBS), an immune-mediated neuropathy, is characterized by antibodies against gangliosides/ganglioside complexes (GSCs) of peripheral nerves. Antecedent infections have been reported to induce antibodies that cross-react with the host gangliosides and thereby have a pivotal role in conferring an increased risk for developing GBS. Data pertaining to the impact of various antecedent infections, particularly those prevalent in tropical countries like India on the ganglioside/GSC antibodies is sparse. We aimed at exploring the association between six antecedent infections and the profile of ganglioside/GSC antibodies in GBS.
Methods: Patients with GBS (n = 150) and healthy controls (n = 50) were examined for the serum profile of antibodies against GM1, GM2, GD1a, GD1b, GT1b, and GQ1b and their GSCs by ELISA. These antibodies were correlated with immunoreactivities against Campylobacter jejuni, Japanese encephalitis (JE), dengue, influenza, zika, and chikungunya infections.
Results: The frequencies of antibodies against six single gangliosides (P < 0.001) and their GSCs (P = 0.039) were significantly higher in patients as compared to controls. Except for GT1b-antibody which was more frequent in axonal GBS, none of the other ganglioside/GSC antibodies correlated with the electrophysiological subtypes of GBS. Antecedent JE infection was significantly associated with increased frequency of antibodies against GD1a, GD1b, GT1b, and GQ1b. Antibodies against GSCs were not influenced by the antecedent infections.
Interpretation: This study for the first time shows an association between antecedent JE infection and ganglioside antibodies in GBS. This finding reinforces the determining role of antecedent infections on ganglioside antibody responses and the subsequent immunological processes in GBS.
Keywords: Antecedent infections; Guillain-Barré syndrome; Japanese encephalitis virus; autoantibodies; ganglioside complex; gangliosides.
Copyright: © 2022 Annals of Indian Academy of Neurology.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Ganglioside complex antibodies in an Indian cohort of Guillain-Barré syndrome.Muscle Nerve. 2020 Dec;62(6):728-734. doi: 10.1002/mus.27071. Epub 2020 Sep 29. Muscle Nerve. 2020. PMID: 32939766
-
[Antiganglioside autoantibody profiles in Guillain-Barré syndrome].Ann Biol Clin (Paris). 2002 Sep-Oct;60(5):589-97. Ann Biol Clin (Paris). 2002. PMID: 12368145 French.
-
Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.J Neurochem. 2011 Mar;116(5):828-32. doi: 10.1111/j.1471-4159.2010.07029.x. Epub 2011 Jan 7. J Neurochem. 2011. PMID: 21214559 Review.
-
Anti-ganglioside complex antibodies associated with severe disability in GBS.J Neuroimmunol. 2007 Jan;182(1-2):212-8. doi: 10.1016/j.jneuroim.2006.09.013. Epub 2006 Nov 16. J Neuroimmunol. 2007. PMID: 17113161
-
Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research.Biochim Biophys Acta. 2008 Mar;1780(3):441-4. doi: 10.1016/j.bbagen.2007.10.001. Epub 2007 Oct 12. Biochim Biophys Acta. 2008. PMID: 17976386 Review.
Cited by
-
Extensive cytokine biomarker analysis in serum of Guillain-Barré syndrome patients.Sci Rep. 2023 May 23;13(1):8354. doi: 10.1038/s41598-023-35610-w. Sci Rep. 2023. PMID: 37221406 Free PMC article.
-
The intersection of influenza infection and autoimmunity.Front Immunol. 2025 Apr 3;16:1558386. doi: 10.3389/fimmu.2025.1558386. eCollection 2025. Front Immunol. 2025. PMID: 40248710 Free PMC article. Review.
-
Relative frequencies and clinical features of Guillain-Barré Syndrome before and during the COVID-19 pandemic in North China.BMC Infect Dis. 2024 May 30;24(1):541. doi: 10.1186/s12879-024-09401-1. BMC Infect Dis. 2024. PMID: 38816802 Free PMC article.
-
Exploratory factor analysis determines latent factors in Guillain-Barré syndrome.Sci Rep. 2022 Dec 17;12(1):21837. doi: 10.1038/s41598-022-26422-5. Sci Rep. 2022. PMID: 36528634 Free PMC article.
-
Guillain-barré syndrome (GBS) with antecedent chikungunya infection: a case report and literature review.Neurol Res Pract. 2024 Apr 11;6(1):21. doi: 10.1186/s42466-024-00315-6. Neurol Res Pract. 2024. PMID: 38600592 Free PMC article. Review.
References
-
- Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382:2574–6. https://doi.org/10.1056/NEJMc2009191. - PMC - PubMed
-
- Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI, de Klerk MA, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study. Neurology. 1998;51:1110–5. - PubMed
-
- Sinha S, Prasad KN, Jain D, Pandey CM, Jha S, Pradhan S. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: A single centre prospective case-control study. Clin Microbiol Infect. 2007;13:334–7. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials